Skip to content

Transcutaneous vagus nerve stimulation at auricular concha for insomnia: basic andclinical research

Transcutaneous vagus nerve stimulation at auricular concha for insomnia: basic andclinical research

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPB-15007097
Enrollment
Unknown
Registered
2015-09-11
Start date
2015-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary insomnia

Interventions

auricular needle group:The second generation earpins instrument

Sponsors

Shanxi hospital of traditional Chinese medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. DSM-V will be used for the diagnosis of sleep disorders: (1) The main problem is difficult to fall asleep, sleeping maintenance difficulty characterized by frequent night awakenings or difficulty falling asleep at least once a month; (2) Obvious trouble or obstacles in social contact, work, education, behavior or other important aspects induced by sleep disturbances (or relevant daytime fatigue); (3) Sleep disorders do not occure at narcolepsy, breathing-Related Sleep disorder andcircadian rhythm sleep disorder onset period; (4) nsomnia cannot be explained by other sleep disorders andout of the course of other sleep disorders (e.g. narcolepsy, breathing-related sleep disorders, sleep-wake rhythm disorders andparasomnias); (5) Sleep difficulty is not induced by physiological?effect of substance abuse. 2. Patients aged between 18-70 years; 3. Patients who can understandthe content of scales andcooperate with the treatment.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Patients with severe primary diseases that involves the heart, brain, liver, kidney andhematopoietic system, or other acute diseases, contagions andmalignancies; 3. Patients with sleep disorders induced by inadequate sleep hygiene; 4. Patients who cannot withdraw relevant medicines as required during the period of treatment.

Design outcomes

Primary

MeasureTime frame
PSQI;

Secondary

MeasureTime frame
HAMD;HAMA;ESS;FSS;SF-36;

Countries

China

Contacts

Public ContactRong Peijing
drrongpj@163.com+86 13718482149

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026